-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Panel Discussion

Program: Special-Interest Sessions
Session: ASH-FDA Joint Symposium: Something Old, Something New - Recent Immunotherapy and Targeted Agent Approvals
Monday, December 12, 2022, 10:30 AM-12:00 PM

Bindu Kanapuru, MD

Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Vienna, VA

Disclosures: No relevant conflicts of interest to declare.

See more of: ASH-FDA Joint Symposium: Something Old, Something New - Recent Immunotherapy and Targeted Agent Approvals
See more of: Special-Interest Sessions
<< Previous Presentation | Next Presentation